Biological Intellectual Property Protection Act of 2025
Congress proposes export licenses for synthetic DNA/RNA sequence files to limit access by foreign entities of concern
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- Would require export licenses for sharing digital files of human-designed synthetic DNA or RNA with certain foreign groups.
- Targets “foreign entities of concern,” including governments and companies tied to countries the U.S. flags as high-risk.
- Covers exports, reexports, and even transfers inside another country when the recipient is a covered foreign entity.
- Sets a 1-year deadline for the Commerce Department to put the license requirement in place.
- Could add paperwork and delays for biotech researchers and companies when collaborating with some overseas partners.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Biological Intellectual Property Protection Act of 2025
Data Sources
Sponsor
Cosponsors
(2)Analysis generated by AI. Always verify with official sources.